Table 1 of
Chung, Mol Vis 2006;
12:415-421.Table 1 of
Chung, Mol Vis 2006;
12:415-421.
Table 1. Experimental solutions
For each of the experimental solutions used in these experiments, the table lists the BAC content, other components, and the source (if purchased). Control and BAC (Sigma-Aldrich) solutions were prepared from tertiary distilled water (DW) or serum free media (SFM; Gibco-Invitrogen). Purchased solutions were all in sterile water for injection (WFI).
Solution BAC Other Source ------------ ------- ------------------ ---------------------------------------- Control 0% SFM (for PCR, WB) BAC media 0.01% SFM Control 0% DW (for TEM) BAC solution 0.01% DW Ocuflox® 0.0025% 0.3% ofloxacin, Samil Pharmaceutical, Seoul, Korea eyedrops WFI Ofloxacin 0% 0.3% ofloxacin, Sigma-Aldrich solution WFI Alcaine® 0.01% 0.5% proparacaine, S. A. Alcon-Couvreur Co., Puurs, Belgium eyedrops WFI Proparacaine 0% 0.5% proparacaine, Sigma-Aldrich solution WFI |